KIT and gastrointestinal stromal tumor: We previously reported that silencing of SH3BP2 leads to a reduction of KIT expression at both mRNA and protein levels, as well as MITF at the protein level, resulting in a decrease in GIST tumor growth in vitro and in vivo [5].